ConductScience.org, home

Paper19620144

Systematic review: glucose control and cardiovascular disease in type 2 diabetes.

Kelly TN and 5 others. Ann Intern Med, 2009. Cited by 258 papers, by iCite.

Cite this record

ConductScience Library. Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Papers, record 19620144. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19620144

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systematic review: glucose control and cardiovascular disease in type 2 diabetes.
PubMed
Journal
Ann Intern Med
PubMed
Year
2009
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Systematic Review
PubMed
Citations, by iCite
258
iCite
Relative citation ratio, by iCite
6.49
iCite
Revised in PubMed
2026-09-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kelly TNTanika N
2Bazzano LALydia A
3Fonseca VAVivian A
4Thethi TKTina K
5Reynolds KKristi
6He JJiang

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiovascular DiseasesMajor topic
Diabetes Mellitus, Type 2Major topic
Hypoglycemic AgentsMajor topic
Blood Glucose
Cause of Death
Humans
Hypoglycemia
Risk Factors

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K08 HL091108NHLBI NIH HHSUnited StatesK08HL091108PubMed and NIHNIH RePORTER
K12 HD043451NICHD NIH HHSUnited StatesK12HD043451PubMed and NIHNIH RePORTER
1K08HL091108NHLBI NIH HHSUnited StatesK08HL091108PubMed and NIHNIH RePORTER
K12HD043451NICHD NIH HHSUnited StatesK12HD043451PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections4

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in20048277Concerns about meta-analysis of glucose control and cardiovascular disease in type 2 diabetes.https://conductscience.org/library/papers/20048277PubMed
Comment in20052788Correction: glucose control and cardiovascular disease in type 2 diabetes.https://conductscience.org/library/papers/20052788PubMed
Comment in20166054[Strict blood glucose control not absolutely required in type 2 diabetes mellitus?].https://conductscience.org/library/papers/20166054PubMed
Comment in20179047Intensive glucose control in type 2 diabetes reduces cardiovascular disease, but not cardiovascular or all-cause mortality, and increases risk of severe hypoglycaemia.https://conductscience.org/library/papers/20179047PubMed

Download CSV of comments and corrections

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119502645A randomized trial of therapies for type 2 diabetes and coronary artery disease.N Engl J Med2009https://conductscience.org/library/papers/19502645PubMed
2430798Diabetes and cardiovascular disease. The Framingham study.JAMA1979https://conductscience.org/library/papers/430798PubMed
312556541Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.N Engl J Med2003https://conductscience.org/library/papers/12556541PubMed
417517853Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.N Engl J Med2007https://conductscience.org/library/papers/17517853PubMed
515562129Trends in cardiovascular complications of diabetes.JAMA2004https://conductscience.org/library/papers/15562129PubMed
617765963Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.Lancet2007https://conductscience.org/library/papers/17765963PubMed
719465231Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.Lancet2009https://conductscience.org/library/papers/19465231PubMed
819092145Glucose control and vascular complications in veterans with type 2 diabetes.N Engl J Med2009https://conductscience.org/library/papers/19092145PubMed
99009975Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.Arch Intern Med1997https://conductscience.org/library/papers/9009975PubMed
1010938048Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.BMJ2000https://conductscience.org/library/papers/10938048PubMed
113802833Meta-analysis in clinical trials.Control Clin Trials1986https://conductscience.org/library/papers/3802833PubMed
1215381515Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.Ann Intern Med2004https://conductscience.org/library/papers/15381515PubMed
1311742409Global and societal implications of the diabetes epidemic.Nature2001https://conductscience.org/library/papers/11742409PubMed
1410860187Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.Diabetes Care2000https://conductscience.org/library/papers/10860187PubMed
1511559264The continuing epidemics of obesity and diabetes in the United States.JAMA2001https://conductscience.org/library/papers/11559264PubMed
1618539918Intensive glycemic control in the ACCORD and ADVANCE trials.N Engl J Med2008https://conductscience.org/library/papers/18539918PubMed
179742976
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Lancet1998https://conductscience.org/library/papers/9742976PubMed
1819380837Glycemic control in type 2 diabetes: time for an evidence-based about-face?Ann Intern Med2009https://conductscience.org/library/papers/19380837PubMed
1917098083Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment.Lancet2006https://conductscience.org/library/papers/17098083PubMed
2016824829Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.Am Heart J2006https://conductscience.org/library/papers/16824829PubMed

See all 33 referencesDownload CSV of references

Cited by133

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 258 citations.

PMIDTitleJournalYearIn PapersSource
41582990A Decade On: The Evolving Renaissance in Intracranial Atherosclerotic Disease.Stroke Vasc Interv Neurol2022https://conductscience.org/library/papers/41582990PubMed
41567802Changes of the cardiac electrical cycle in type 1 diabetes during hypoglycaemia - a prospective observational study.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41567802PubMed
41559660Cost of diabetes and hypertension services delivered in primary and secondary-level government facilities in Punjab, India.BMC Health Serv Res2026https://conductscience.org/library/papers/41559660PubMed
41034186History of Hypertension From Childhood and Fasting Blood Glucose Levels in Adulthood: The Bogalusa Study.J Diabetes2025https://conductscience.org/library/papers/41034186PubMed
40477401Crocodile blood supplementation protects vascular function in diabetic mice.Food Prod Process Nutr2021https://conductscience.org/library/papers/40477401PubMed
40329991Morbidity-bridging metabolic pathways: linking early cardiovascular disease risk and depression symptoms using a multi-modal approach.Eur Heart J Open2025https://conductscience.org/library/papers/40329991PubMed
39339760Licorice Extract Isoliquiritigenin Protects Endothelial Function in Type 2 Diabetic Mice.Nutrients2024https://conductscience.org/library/papers/39339760PubMed
39156155Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched Study.Kidney Int Rep2024https://conductscience.org/library/papers/39156155PubMed
37746464Exploring the Relation Between Diabetes and HIV: A Narrative Review.Cureus2023https://conductscience.org/library/papers/37746464PubMed
37645418Association of hypoglycaemia with the risks of arrhythmia and mortality in individuals with diabetes - a systematic review and meta-analysis.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37645418PubMed
36941489Weight Loss Versus Glycemic Control as the Primary Treatment Target in Newly Diagnosed Type 2 Diabetes: Why Choose When You Can Have Both?Drugs2023https://conductscience.org/library/papers/36941489PubMed
36574434Effect of repeated bolus and continuous glucose infusion on a panel of circulating biomarkers in healthy volunteers.PLoS One2022https://conductscience.org/library/papers/36574434PubMed
36432488Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches.Nutrients2022https://conductscience.org/library/papers/36432488PubMed
36299875Hypoglycemia is associated with a higher risk of mortality and arrhythmias in ST-elevation myocardial infarction, irrespective of diabetes.Front Cardiovasc Med2022https://conductscience.org/library/papers/36299875PubMed
35929480Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment.Diabetes Obes Metab2022https://conductscience.org/library/papers/35929480PubMed
34902079Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes.Curr Diab Rep2021https://conductscience.org/library/papers/34902079PubMed
34795807mtDNA in the Pathogenesis of Cardiovascular Diseases.Dis Markers2021https://conductscience.org/library/papers/34795807PubMed
34277996Association of type 2 diabetes remission and risk of cardiovascular disease in pre-defined subgroups.Endocrinol Diabetes Metab2021https://conductscience.org/library/papers/34277996PubMed
34258663Risk factor management and OCT characteristics of plaque vulnerability: the Holy Grail of plaque and patient vulnerability.Int J Cardiovasc Imaging2022https://conductscience.org/library/papers/34258663PubMed
34177225Enhancing Diabetes Self-Management Education and Psychological Services for Veterans With Comorbid Chronic Health and Mental Health Conditions.Fed Pract2021https://conductscience.org/library/papers/34177225PubMed

See all 133 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19620144

GET https://conductscience.org/api/papers/v1/19620144/references?page=2